About CSA Medical
CSA Medical is a private company based in Lexington, Massachusetts. It has reported $159,649,396 raised in 11 offerings on Form D since December 2011. Its chief executive is Wendelin Maners.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 8, 2026 | Jul 23, 2026 | $2,908,295of $11.2M target | 40 | $72,707 | EquityRule 506(b) | Form D ↗ |
| Aug 30, 2024 | Sep 18, 2024 | $59,663,552of $71.1M target | 52 | $1.1M | EquityRule 506(b) | Form D ↗ |
| Jan 25, 2019 | Feb 7, 2019 | $45,218,361of $47.7M target | 37 | $1.2M | EquityRule 506(b) | Form D ↗ |
| Dec 21, 2017 | Feb 7, 2019 | $5,083,214fully sold | 39 | $130K | DebtRule 506(b) | Form D ↗ |
| May 31, 2017 | Jun 12, 2017 | $4,183,871of $6.3M target | 10 | $418K | DebtRule 506(b) | Form D ↗ |
| Nov 21, 2016 | Dec 5, 2016 | $2,900,000of $7.7M target | 9 | $322K | Debt, OptionsRule 506(b) | Form D ↗ |
| Jun 29, 2015 | Jul 13, 2015 | $6,564,801of $6.5M target | 26 | $252K | Debt, OptionsRule 506(b) | Form D ↗ |
| Jun 29, 2015 | Jul 13, 2015 | $299,999fully sold | 1 | $299K | OptionsRule 506(b) | Form D ↗ |
| Apr 2, 2015 | Apr 16, 2015 | $2,927,303of $3.9M target | 30 | $97,577 | Debt, OptionsRule 506(b) | Form D ↗ |
| Dec 18, 2013 | Jan 3, 2014 | $16,000,000fully sold | 8 | $2.0M | EquityRule 506(b) | Form D ↗ |
| Nov 18, 2011 | Dec 1, 2011 | $13,900,000of $21.0M target | 5 | $2.7M | Equity, Options06 | Form D ↗ |
| Total, 11 offerings | $159,649,396 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on CSA Medical's Form D filed Jul 23, 2026.
Earlier filings also listed Tara Butler, M.D. (director, last listed Sep 2024), Tracy Marshbanks (director, last listed Feb 2019), Thomas Snead (director, last listed Feb 2019), Tara Butler (director, last listed Feb 2019), Richard Kent (director, last listed Feb 2019), Paul Lavoiolette (director, last listed Feb 2019), Ellen Sheets (executive officer and director, last listed Feb 2019) and Ian Vawter (cfo, last listed Dec 2016).